Grown Rogue International (GRUSF) Shares Outstanding (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Shares Outstanding (Entity) of $249.9 million for Q1 2026, up 10.0% year-over-year from $227.2 million in Q1 2025, and up 2.66% quarter-over-quarter from $243.4 million in Q4 2025.
Grown Rogue International (GRUSF) Shares Outstanding (2009 - 2026) Analysis & Trends
Grown Rogue International's Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $249.9 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 10.0% year-over-year to $249.9 million; the TTM figure through Mar 2026 stood at $249.9 million (up 10.0% YoY), while the FY2025 annual figure was $243.4 million, up 2.53% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $249.9 million, up from $243.4 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $249.9 million in Q1 2026, with the low at $165.0 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $205.4 million (2023), against an average of $205.5 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) jumped 52.7% in 2022, then rose 2.08% in 2023.
- Grown Rogue International's Shares Outstanding (Entity) stood at $169.2 million in 2022, then advanced by 26.51% to $214.0 million in 2023, then gained by 10.92% to $237.4 million in 2024, then rose by 2.53% to $243.4 million in 2025, then rose by 2.66% to $249.9 million in 2026.
- Business Quant data shows GRUSF's Shares Outstanding (Entity) at $249.9 million in Q1 2026, $243.4 million in Q4 2025, and $249.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 832.44 Mn |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 249.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 249.94 Mn |
| Mar 31, 2026 | 249.91 Mn |
| Dec 31, 2025 | 243.45 Mn |
| Sep 30, 2025 | 249.56 Mn |
| Jun 30, 2025 | 246.99 Mn |
| Mar 31, 2025 | 227.19 Mn |
| Dec 31, 2024 | 237.43 Mn |
| Sep 30, 2024 | 221.21 Mn |
| Jun 30, 2024 | 196.81 Mn |
| Mar 31, 2024 | 183.18 Mn |
| Dec 31, 2023 | 214.05 Mn |
| Oct 31, 2023 | 172.71 Mn |
| Jul 31, 2023 | 170.83 Mn |
| Apr 30, 2023 | 170.83 Mn |
| Jan 31, 2023 | 169.19 Mn |
| Oct 31, 2022 | 169.19 Mn |
| Jan 31, 2022 | 164.98 Mn |
| Oct 31, 2021 | 135.23 Mn |
| Jul 31, 2021 | 163.25 Mn |
| Apr 30, 2021 | 120.24 Mn |